HMGB2 and central nervous system cancer: 3.3. High HMGB2 Expression, Both at mRNA and Protein Levels, Is an Early Marker of Worse Overall Survival in Grades 2 and 3 Diffuse Gliomas, and It Is, at Least in Part, Regulated by DNA Methylation